表紙:米国の臨床栄養市場 (2022年-2028年):市場予測 (製品・消費者・用途・流通チャネル別)・用途の潜在性・価格動向・市場シェア
市場調査レポート
商品コード
1064545

米国の臨床栄養市場 (2022年-2028年):市場予測 (製品・消費者・用途・流通チャネル別)・用途の潜在性・価格動向・市場シェア

U.S. Clinical Nutrition Market Size By Product, By Consumer, By Application, By Distribution Channel, Industry Analysis Report, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 80 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
米国の臨床栄養市場 (2022年-2028年):市場予測 (製品・消費者・用途・流通チャネル別)・用途の潜在性・価格動向・市場シェア
出版日: 2022年03月04日
発行: Global Market Insights Inc.
ページ情報: 英文 80 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の臨床栄養の市場は、同地域の消費者の健康意識の高まりを背景に、2028年にかけて飛躍的な成長が見込まれています。

製品別で見ると、乳児栄養の部門が予測期間中安定したCAGRで推移し、2028年には111億8,300万米ドル超の規模に成長すると予測されています。米国では早産が増加し、出生率が上昇しているため、今後数年の成長を促進すると予測されています。また、消費者別では、小児の部門が主要な市場シェアを占め、2028年末には119億700万米ドル超の規模を示すと予測されています。多くの慢性疾患や心血管疾患を患う患者数が増加しており、今後数年の需要を牽引する可能性があります。

当レポートでは、米国の臨床栄養の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、市場規模の推移・予測、製品・消費者・用途・流通チャネルなど各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 米国の臨床栄養産業の考察

  • 産業の分類
  • 産業情勢
  • 産業への影響要因
    • 成長要因
    • 潜在的リスク&課題
  • 成長の可能性の分析
  • COVID-19:影響分析
  • 規制状況
  • ポーターの分析
  • 競合情勢
  • PESTEL分析

第4章 米国の臨床栄養市場:製品別

  • 主要動向
  • 乳児栄養
    • ミルクベース
    • 大豆ベース
    • 有機調整乳
    • その他
  • 経腸栄養
    • 標準調合
    • 疾患専用調合
  • 非経口栄養
    • アミノ酸
    • 脂肪
    • 炭水化物
    • その他

第5章 米国の臨床栄養市場:消費者別

  • 主要動向
  • 小児
  • 成人

第6章 米国の臨床栄養市場:用途別

  • 主要動向
  • 代謝障害
  • 神経疾患
  • 胃腸障害
  • その他

第7章 米国の臨床栄養市場:流通チャネル別

  • 主要動向
  • 小売店
  • 薬局・ドラッグストア
  • オンライン
  • その他

第8章 企業プロファイル

  • 戦略ダッシュボード
  • Abbott Laboratories(Abbott Nutrition)
  • B Braun Melsungen AG
  • Baxter International Inc
  • Fresenius Kabi
  • Mead Johnson(Reckitt Benckiser)
  • Nestle Health Science
  • Perrigo Co.
  • Pfizer, Inc.
  • Danone
  • Hero Nutritionals Inc.
図表

Data Tables

  • TABLE 1 U.S. Clinical nutrition industry 360 degree synopsis, 2017-2028
  • TABLE 2 U.S. clinical nutrition market, 2017-2021 (USD Million)
  • TABLE 3 U.S. clinical nutrition market, 2022-2028 (USD Million)
  • TABLE 4 Industry impact forces
  • TABLE 5 U.S. infant nutrition market size, 2017-2021 (USD Million)
  • TABLE 6 U.S. infant nutrition market size, 2022-2028 (USD Million)
  • TABLE 7 U.S. milk-based market size, 2017-2021 (USD Million)
  • TABLE 8 U.S. milk-based market size, 2022-2028 (USD Million)
  • TABLE 9 U.S. soy-based market size, 2017-2021 (USD Million)
  • TABLE 10 U.S. soy-based market size, 2022-2028 (USD Million)
  • TABLE 11 U.S. organic formulas market size, 2017-2021 (USD Million)
  • TABLE 12 U.S. organic formulas market size, 2022-2028 (USD Million)
  • TABLE 13 U.S. others market size, 2017-2021 (USD Million)
  • TABLE 14 U.S. others market size, 2022-2028 (USD Million)
  • TABLE 15 U.S. enteral nutrition market size, 2017-2021 (USD Million)
  • TABLE 16 U.S. enteral nutrition market size, 2022-2028 (USD Million)
  • TABLE 17 U.S. standard composition market size, 2017-2021 (USD Million)
  • TABLE 18 U.S. standard composition market size, 2022-2028 (USD Million)
  • TABLE 19 U.S. disease specific composition market size, 2017-2021 (USD Million)
  • TABLE 20 U.S. disease specific composition market size, 2022-2028 (USD Million)
  • TABLE 21 U.S. parenteral nutrition market size, 2017-2021 (USD Million)
  • TABLE 22 U.S. parenteral nutrition market size, 2022-2028 (USD Million)
  • TABLE 23 U.S. amino acids market size, 2017-2021 (USD Million)
  • TABLE 24 U.S. amino acids market size, 2022-2028 (USD Million)
  • TABLE 25 U.S. fats market size, 2017-2021 (USD Million)
  • TABLE 26 U.S. fats market size, 2022-2028 (USD Million)
  • TABLE 27 U.S. carbohydrates market size, 2017-2021 (USD Million)
  • TABLE 28 U.S. carbohydrates market size, 2022-2028 (USD Million)
  • TABLE 29 U.S. others market size, 2017-2021 (USD Million)
  • TABLE 30 U.S. others market size, 2022-2028 (USD Million)
  • TABLE 31 U.S. pediatric market size, 2017-2021 (USD Million)
  • TABLE 32 U.S. pediatric market size, 2022-2028 (USD Million)
  • TABLE 33 U.S. adult market size, 2017-2021 (USD Million)
  • TABLE 34 U.S. adult market size, 2022-2028 (USD Million)
  • TABLE 35 U.S. cancer market size, 2017-2021 (USD Million)
  • TABLE 36 U.S. cancer market size, 2022-2028 (USD Million)
  • TABLE 37 U.S. metabolic disorders market size, 2017-2021 (USD Million)
  • TABLE 38 U.S. metabolic disorders market size, 2022-2028 (USD Million)
  • TABLE 39 U.S. neurological diseases market size, 2017-2021 (USD Million)
  • TABLE 40 U.S. neurological diseases market size, 2022-2028 (USD Million)
  • TABLE 41 U.S. gastrointestinal disorders market size, 2017-2021 (USD Million)
  • TABLE 42 U.S. gastrointestinal disorders market size, 2022-2028 (USD Million)
  • TABLE 43 U.S. others market size, 2017-2021 (USD Million)
  • TABLE 44 U.S. others market size, 2022-2028 (USD Million)
  • TABLE 45 U.S. retail stores market size, 2017-2021 (USD Million)
  • TABLE 46 U.S. retail stores market size, 2022-2028 (USD Million)
  • TABLE 47 U.S. pharmacies and drug stores market size, 2017-2021 (USD Million)
  • TABLE 48 U.S. pharmacies and drug stores, 2022-2028 (USD Million)
  • TABLE 49 U.S. online channels market size, 2017-2021 (USD Million)
  • TABLE 50 U.S. online channels market size, 2022-2028 (USD Million)
  • TABLE 51 U.S. others market size, 2017-2021 (USD Million)
  • TABLE 52 U.S. others market size, 2022-2028 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (supply side analysis)
  • FIG. 2 Industry segmentation
  • FIG. 3 U.S. clinical nutrition market size, 2017 - 2028 (USD Million)
  • FIG. 4 Growth potential analysis, by product
  • FIG. 5 Growth potential analysis, by consumer
  • FIG. 6 Growth potential analysis, by application
  • FIG. 7 Growth potential analysis, by distribution channel
  • FIG. 8 Porter's analysis
  • FIG. 9 Competitive matrix analysis, 2021
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by product
  • FIG. 12 Key segment trends, by consumer
  • FIG. 13 Key segment trends, by application
  • FIG. 14 Key segment trends, by distribution channel
  • FIG. 15 Competitive dashboard, 2021
目次
Product Code: 4514

The U.S. clinical nutrition market is expected to witness exponential growth through 2028 on account of rising health consciousness among consumers in the region.

Recently, industry players have been adopting profitable strategies to extend their consumer reach, which has been favorable for business growth. For instance, in February 2022, Nestle Health Science, an American clinical nutrition expert, completed the acquisition of Vital Proteins, a leading specialist in collagen in the U.S. and a major provider of beverages, supplements, and food products. With the takeover, Nestle intended to expand its brand geographically, focus on product innovation, and scale up R&D activities, while capitalizing on proliferating consumer interest in collagen.

The U.S. clinical nutrition market has been bifurcated in terms of product, consumer, application, and distribution channel. Based on product, the market has further been segregated into enteral nutrition, infant nutrition, and parenteral nutrition. The infant nutrition sub-segment is expected to reach more than USD 11,183 million in revenue by 2028, growing at a steady CAGR over the study timeframe. Increasing premature birth and rising birth rate in the U.S. is slated to foster segmental outlook in the forthcoming years.

On the basis of consumer, the U.S. clinical nutrition market has been segmented into adult and pediatric. In 2021, the pediatric sub-segment accounted for a major market share and is anticipated to experience notable growth over the analysis timeframe to be valued at over USD 11,907 million by the end of 2028. Mounting patient population suffering from numerous chronic and cardiovascular diseases in the U.S. is likely to drive segmental demand in the coming years.

By application, the U.S. clinical nutrition market has been divided into metabolic disorders, cancer, gastrointestinal disorders, neurological diseases, and others. The metabolic disorders sub-segment accounted for a notable market share in 2021 and is projected to progress at a solid pace to garner a revenue of about USD 6,377 million by 2028. Rising prevalence of numerous types of metabolic disorders among the geriatric population in the country is set to bolster segmental development in the future.

From the distribution channel perspective, the U.S. clinical nutrition market has been classified into retail stores, online channels, pharmacies & drug stores, and others. In 2021, the retail stores sub-segment held a considerable share in the market and is primed to witness healthy growth through the forecast timespan to attain a valuation of above USD 8,334 million by 2028. Soaring adoption and easy accessibility of clinical nutrition products in the country are foreseen to promote the growth of the segment over the following years.

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 U.S. clinical nutrition industry 360 degree synopsis, 2017 - 2028 (USD Million)
    • 2.1.1 Business trends

Chapter 3 US Clinical Nutrition Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing metabolic disorders and other chronic diseases
      • 3.3.1.2 High junk food consumption leading to malnourishment
      • 3.3.1.3 Rising geriatric population
      • 3.3.1.4 Increasing incidence of pre-mature birth & birth rate
      • 3.3.1.5 Increasing adoption of home healthcare
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Stringent government regulations
      • 3.3.2.2 Lack of awareness
  • 3.4 Growth potential analysis
    • 3.4.1 By product
    • 3.4.2 By consumer
    • 3.4.3 By application
    • 3.4.4 By distribution channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Regulatory landscape
  • 3.7 Porter's analysis
  • 3.8 Competitive landscape, 2021
    • 3.8.1 Company matrix analysis, 2021
  • 3.9 PESTEL analysis

Chapter 4 US Clinical Nutrition Market, By Product

  • 4.1 Key segment trends
  • 4.2 Infant Nutrition
    • 4.2.1 Market size, 2017 - 2028 (USD Million)
    • 4.2.2 Milk Based
      • 4.2.2.1 Market size, 2017 - 2028 (USD Million)
    • 4.2.3 Soy Based
      • 4.2.3.1 Market size, 2017 - 2028 (USD Million)
    • 4.2.4 Organic formulas
      • 4.2.4.1 Market size, 2017 - 2028 (USD Million)
    • 4.2.5 Others
      • 4.2.5.1 Market size, 2017 - 2028 (USD Million)
  • 4.3 Enteral Nutrition
    • 4.3.1 Standard composition
      • 4.3.1.1 Market size, 2017 - 2028 (USD Million)
    • 4.3.2 Disease specific composition
      • 4.3.2.1 Market size, 2017 - 2028 (USD Million)
  • 4.4 Parenteral Nutrition
    • 4.4.1 Market size, 2017 - 2028 (USD Million)
    • 4.4.2 Amino Acids
      • 4.4.2.1 Market size, 2017 - 2028 (USD Million)
    • 4.4.3 Fats
      • 4.4.3.1 Market size, 2017 - 2028 (USD Million)
    • 4.4.4 Carbohydrates
      • 4.4.4.1 Market size, 2017 - 2028 (USD Million)
    • 4.4.5 Others
      • 4.4.5.1 Market size, 2017 - 2028 (USD Million)

Chapter 5 US Clinical Nutrition Market, By Consumer

  • 5.1 Key segment trends
  • 5.2 Pediatric
    • 5.2.1 Market size, 2017 - 2028 (USD Million)
  • 5.3 Adult
    • 5.3.1 Market size, 2017 - 2028 (USD Million)

Chapter 6 US Clinical Nutrition Market, By Application

  • 6.1 Key segment trends
  • 6.2 Cancer
    • 6.2.1 Market size, 2017 - 2028 (USD Million)
  • 6.3 Metabolic Disorders
    • 6.3.1 Market size, 2017 - 2028 (USD Million)
  • 6.4 Neurological Diseases
    • 6.4.1 Market size, 2017 - 2028 (USD Million)
  • 6.5 Gastrointestinal Disorders
    • 6.5.1 Market size, 2017 - 2028 (USD Million)
  • 6.6 Others
    • 6.6.1 Market size, 2017 - 2028 (USD Million)

Chapter 7 US Clinical Nutrition Market, By Distribution Channel

  • 7.1 Key segment trends
  • 7.2 Retail Stores
    • 7.2.1 Market size, 2017 - 2028 (USD Million)
  • 7.3 Pharmacies & Drug Stores
    • 7.3.1 Market size, 2017 - 2028 (USD Million)
  • 7.4 Online Channels
    • 7.4.1 Market size, 2017 - 2028 (USD Million)
  • 7.5 Others
    • 7.5.1 Market size, 2017 - 2028 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Strategy dashboard, 2021
  • 8.2 Abbott Laboratories (Abbott Nutrition)
    • 8.2.1 Business overview
    • 8.2.2 Financial data
    • 8.2.3 Product landscape
    • 8.2.4 Strategic outlook
    • 8.2.5 SWOT analysis
  • 8.3 B Braun Melsungen AG
    • 8.3.1 Business overview
    • 8.3.2 Financial data
    • 8.3.3 Product landscape
    • 8.3.4 Strategic outlook
    • 8.3.5 SWOT analysis
  • 8.4 Baxter International Inc
    • 8.4.1 Business overview
    • 8.4.2 Financial data
    • 8.4.3 Product landscape
    • 8.4.4 Strategic outlook
    • 8.4.5 SWOT analysis
  • 8.5 Fresenius Kabi
    • 8.5.1 Business overview
    • 8.5.2 Financial data
    • 8.5.3 Product landscape
    • 8.5.4 Strategic outlook
    • 8.5.5 SWOT analysis
  • 8.6 Mead Johnson (Reckitt Benckiser)
    • 8.6.1 Business overview
    • 8.6.2 Financial data
    • 8.6.3 Product landscape
    • 8.6.4 Strategic outlook
    • 8.6.5 SWOT analysis
  • 8.7 Nestle Health Science
    • 8.7.1 Business overview
    • 8.7.2 Financial data
    • 8.7.3 Product landscape
    • 8.7.4 Strategic outlook
    • 8.7.5 SWOT analysis
  • 8.8 Perrigo Co.
    • 8.8.1 Business overview
    • 8.8.2 Financial data
    • 8.8.3 Product landscape
    • 8.8.4 Strategic outlook
    • 8.8.5 SWOT analysis
  • 8.9 Pfizer, Inc.
    • 8.9.1 Business overview
    • 8.9.2 Financial data
    • 8.9.3 Product landscape
    • 8.9.4 Strategic outlook
    • 8.9.5 SWOT analysis
  • 8.10 Danone
    • 8.10.1 Business overview
    • 8.10.2 Financial data
    • 8.10.3 Product landscape
    • 8.10.4 Strategic outlook
    • 8.10.5 SWOT analysis
  • 8.11 Hero Nutritionals Inc.
    • 8.11.1 Business overview
    • 8.11.2 Financial data
    • 8.11.3 Product landscape
    • 8.11.4 Strategic outlook
    • 8.11.5 SWOT analysis